Nutraceuticals Market by Type, (Functional Beverage, Functional Food, and Dietary Supplements), Form (Capsules and Tablets, Liquid, Powder, Others), and Sales Channel (Hypermarkets/Supermarkets, Specialty Stores, Pharmacies, and Online Channels): Global O

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,126	325 Pages	Allied Market Research	January, 2022	ALMR17046177

Best Price Guarantee
Price	from $4,126
Length	325 Pages
Publisher	Allied Market Research
Published Date	January, 2022
SKU	ALMR17046177

Nutraceuticals Market by Type, (Functional Beverage, Functional Food, and Dietary Supplements), Form (Capsules and Tablets, Liquid, Powder, Others), and Sales Channel (Hypermarkets/Supermarkets, Specialty Stores, Pharmacies, and Online Channels): Global Opportunity Analysis and Industry Forecast, 2021–2030

Nutraceuticals are health products that are labelled under foods but are also utilized for medicinal purposes. They are also called bioceuticals as they are made from food materials and extracts. Nutraceuticals s are used for treatment and prevention of diseases and as supplements to maintain and improve health and wellbeing, prevent chronic diseases, delay aging, support the structure or function of the body, and increase life expectancy. There are various types of Nutraceuticals products available in the market that are used for a variety of applications. As these products are considered to be food supplements or additives, they are unregulated in many countries across the world.

Consumer across the world are looking for customizable food, beverages, and dietary solutions that will help them more aggressively meet their own unique nutrition and personal health goals. Active and health-conscious consumers have shifted their preference toward natural alternatives for sugar-based drinks that are rich in carbohydrates and unhealthy chemicals. Functional beverages consist of specific nutrients and supplements, which enhance athletic performance and metabolism. Appropriate nutrition is an essential prerequisite for effective improvement of athletic performance, conditioning, recovery from fatigue after exercise, and rapid recovery of injury. In addition, it helps in diabetes management. Changes in lifestyle of consumers has been one of the major factors that has contributed toward the growing popularity of functional food in developing economies. In Asia-Pacific countries, surge in per capita income has led to changing food habits of customers. Rise in aspiration and penchant for luxury lifestyle has led to manifold increase in market size and overall demand.

Demand for Nutraceuticals products is growing rapidly. The main reason for this increase is the increasing awareness regarding the health and wellness benefits due to the consumption of Nutraceuticals supplements. Furthermore, adoption of severe lifestyles due to work pressure and greater consumption of fast food is propelling consumers to search for supplements that can help in maintaining wellbeing of the consumers. Increasing consumption of unhealthy food is leading to diseases like high cholesterol, obesity, bone degradation, and heart related diseases. More consumers are reporting increase in fitness activities like visiting gyms and athletic centers to maintain health, and are coupling these activities with Nutraceuticals s in order to gain maximum results.

Many consumers are avoiding chemical ingredients in their food, health food, functional food, proteins, and Nutraceuticals products. Hence, demand for naturally sourced ingredients and herbal canned tomatoes is increasing continuously. This demand is mainly increasing in developed regions of North America and Europe as consumers in this region are spending more on natural products compared to consumers in other regions. Newer types of Nutraceuticals s in the forms of gummies, jellies, and soft gels are being introduced in the market and their adoption is gradually increasing, they are available in a myriad of shapes, sizes, flavors and concentrations. Most of these Nutraceuticals s are intended for daily consumption, and hence these varieties make it possible for consumers to have these Nutraceuticals daily if they are perceived to be fun to consume.

The global Nutraceuticals market is segmented on the basis of type, form, sales channel, and region. Based on type, the global market is bifurcated into functional beverage, functional food, and dietary supplements. By form the market is segmented into capsules and tablets, liquid, powder, others. Based on sales channel the global market is studied across hypermarkets/supermarkets, specialty stores, pharmacies, and online channels. The global Nutraceuticals market is also studied across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major players profiled for in the Nutraceuticals market analysis Archer Daniels Midland Company, BASF SE, Cargill, Inc., Danone, DuPont de Nemours, Inc., General Mills Inc., Koninklijke DSM N.V., Nestle S.A., PepsiCo, Inc., and Yakult Honsha Co., Ltd.

Nutraceuticals Market Segments

By Type

Functional Beverage
Functional Food
Dietary Supplement

By Form

Capsule and Tablets
Liquid
Powder
Others

By Sales Channel

Hypermarket/Supermarket
Specialty Stores
Pharmacy
Online Channels

By Region

North America
U.S.
Canada
Mexico
Europe
UK
Germany
Italy
France
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Argentina
Saudi Arabia
United Arab Emirates
South Africa
Rest of LAMEA

Key Market Players

Archer Daniels Midland Company
BASF SE
Cargill, Inc.
Danone
DuPont de Nemours, Inc.
General Mills Inc,
Koninklijke DSM N.V.
Nestle S.A.
PepsiCo, Inc.
Yakult Honsha Co., Ltd.

List of Company Profiles

Archer Daniels Midland Company
BASF SE, Cargill, Inc.
Danone
DuPont de Nemours, Inc.
General Mills Inc.
Koninklijke DSM N.V.
Nestle S.A.
PepsiCo, Inc.
Yakult Honsha Co., Ltd.

CHAPTER 1:INTRODUCTION: 1.1.Report description; 1.2.Key benefits for stakeholders; 1.3.Key market segments; 1.4.Research methodology; 1.4.1.Primary research; 1.4.2.Secondary research; 1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY: 2.1.Key findings; 2.1.1.Top impacting factors; 2.1.2.Top investment pockets; 2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW: 3.1.Market definition and scope; 3.2.Porter's five forces analysis; 3.2.1.Bargaining power of suppliers; 3.2.2.Bargaining power of buyers; 3.2.3.Threat of substitution; 3.2.4.Threat of new entrants; 3.2.5.Intensity of competitive rivalry; 3.3.Market dynamics; 3.3.1.Drivers; 3.3.1.1.Increase in demand for functional food in developing nations; 3.3.1.2.Rise in consumption of sports and energy drinks.; 3.3.1.3.Increase in purchasing power and changes in lifestyle and food habits.; 3.3.1.4.Increasing demand for nutraceuticals to supplement regular diet; 3.3.2.Restraints; 3.3.2.1.Counterfeit and low quality products affecting the market.; 3.3.2.2.Challenges related to manufacturing technology and processing.; 3.3.3.Opportunities; 3.3.3.1.Greater demands for herbal nutraceutical products can help the market grow.; 3.3.3.2.New format of intakes of nutraceuticals; 3.4.Covid-19 analysis; 3.4.1.Overview:; 3.4.2.Impact on food and beverage sector:; 3.4.3.Impact on nutraceuticals market:; 3.5.Supply chain analysis; 3.6.Consumer survey analysis
CHAPTER 4:NUTRACEUTICALS MARKET, BY TYPE: 4.1.Overview; 4.1.1.Market size and forecast, by Type; 4.2.Functional beverages; 4.2.1.Key market trends, growth factors, and opportunities; 4.2.1.1.Energy and Sports Drinks-; 4.2.1.2.Functional Juices –; 4.2.1.3.Others; 4.2.2.Market size and forecast, by region; 4.2.3.Market analysis, by country; 4.3.Functional food; 4.3.1.Key market trends, growth factors, and opportunities; 4.3.1.1.Probiotics-; 4.3.1.2.Minerals-; 4.3.1.3.Proteins & Amino Acids-; 4.3.1.4.Prebiotics, & Dietary Fibers-; 4.3.1.5.Vitamins-; 4.3.1.6.Others-; 4.3.2.Market size and forecast, by region; 4.3.3.Market analysis, by country; 4.4.Dietary supplements; 4.4.1.Key market trends, growth factors, and opportunities; 4.4.1.1.Vitamins-; 4.4.1.2.Botanicals-; 4.4.1.3.Minerals-; 4.4.1.4.Proteins & Amino Acids-; 4.4.1.5.Fibers & Specialty Carbohydrates-; 4.4.1.6.Omega Fatty Acids-; 4.4.1.7.Others-; 4.4.2.Market size and forecast, by region; 4.4.3.Market analysis, by country
CHAPTER 5:NUTRACEUTICALS MARKET, BY FORM: 5.1.Overview; 5.1.1.Market size and forecast, by Form; 5.2.Capsule and tablets; 5.2.1.Key market trends, growth factors, and opportunities; 5.2.2.Market size and forecast, by region; 5.2.3.Market analysis, by country; 5.3.Liquid; 5.3.1.Key market trends, growth factors, and opportunities; 5.3.2.Market size and forecast, by region; 5.3.3.Market analysis, by country; 5.4.Powder; 5.4.1.Key market trends, growth factors, and opportunities; 5.4.2.Market size and forecast, by region; 5.4.3.Market analysis, by country; 5.5.Others; 5.5.1.Key market trends, growth factors, and opportunities; 5.5.2.Market size and forecast, by region; 5.5.3.Market analysis, by country
CHAPTER 6:NUTRACEUTICALS MARKET, BY SALES CHANNEL: 6.1.Overview; 6.1.1.Market size and forecast, by Sales channel; 6.2.Hypermarket/Supermarket; 6.2.1.Key market trends, growth factors, and opportunities; 6.2.2.Market size and forecast, by region; 6.2.3.Market analysis, by country; 6.3.Specialty stores; 6.3.1.Key market trends, growth factors, and opportunities; 6.3.2.Market size and forecast, by region; 6.3.3.Market analysis, by country; 6.4.Pharmacy; 6.4.1.Key market trends, growth factors, and opportunities; 6.4.2.Market size and forecast, by region; 6.4.3.Market analysis, by country; 6.5.Online channels; 6.5.1.Key market trends, growth factors, and opportunities; 6.5.2.Market size and forecast, by region; 6.5.3.Market analysis, by country
CHAPTER 7:NUTRACEUTICALS MARKET, BY REGION: 7.1.Overview; 7.1.1.Market size and forecast, by region; 7.2.North America; 7.2.1.Key market trends, growth factors, and opportunities; 7.2.2.Market size and forecast, by Type; 7.2.3.Market size and forecast, by Form; 7.2.4.Market size and forecast, by Sales channel; 7.2.5.Market analysis, by Country; 7.2.5.1.U.S.; 7.2.5.1.1.Market size and forecast, by Type; 7.2.5.1.2.Market size and forecast, by Form; 7.2.5.1.3.Market size and forecast, by Sales channel; 7.2.5.2.Canada; 7.2.5.2.1.Market size and forecast, by Type; 7.2.5.2.2.Market size and forecast, by Form; 7.2.5.2.3.Market size and forecast, by Sales channel; 7.2.5.3.Mexico; 7.2.5.3.1.Market size and forecast, by Type; 7.2.5.3.2.Market size and forecast, by Form; 7.2.5.3.3.Market size and forecast, by Sales channel; 7.3.Europe; 7.3.1.Key market trends, growth factors, and opportunities; 7.3.2.Market size and forecast, by Type; 7.3.3.Market size and forecast, by Form; 7.3.4.Market size and forecast, by Sales channel; 7.3.5.Market analysis, by Country; 7.3.5.1.UK; 7.3.5.1.1.Market size and forecast, by Type; 7.3.5.1.2.Market size and forecast, by Form; 7.3.5.1.3.Market size and forecast, by Sales channel; 7.3.5.2.Germany; 7.3.5.2.1.Market size and forecast, by Type; 7.3.5.2.2.Market size and forecast, by Form; 7.3.5.2.3.Market size and forecast, by Sales channel; 7.3.5.3.Italy; 7.3.5.3.1.Market size and forecast, by Type; 7.3.5.3.2.Market size and forecast, by Form; 7.3.5.3.3.Market size and forecast, by Sales channel; 7.3.5.4.France; 7.3.5.4.1.Market size and forecast, by Type; 7.3.5.4.2.Market size and forecast, by Form; 7.3.5.4.3.Market size and forecast, by Sales channel; 7.3.5.5.Spain; 7.3.5.5.1.Market size and forecast, by Type; 7.3.5.5.2.Market size and forecast, by Form; 7.3.5.5.3.Market size and forecast, by Sales channel; 7.3.5.6.Rest of Europe; 7.3.5.6.1.Market size and forecast, by Type; 7.3.5.6.2.Market size and forecast, by Form; 7.3.5.6.3.Market size and forecast, by Sales channel; 7.4.Asia-Pacific; 7.4.1.Key market trends, growth factors, and opportunities; 7.4.2.Market size and forecast, by Type; 7.4.3.Market size and forecast, by Form; 7.4.4.Market size and forecast, by Sales channel; 7.4.5.Market analysis, by country; 7.4.5.1.China; 7.4.5.1.1.Market size and forecast, by Type; 7.4.5.1.2.Market size and forecast, by Form; 7.4.5.1.3.Market size and forecast, by Sales channel; 7.4.5.2.Japan; 7.4.5.2.1.Market size and forecast, by Type; 7.4.5.2.2.Market size and forecast, by Form; 7.4.5.2.3.Market size and forecast, by Sales channel; 7.4.5.3.India; 7.4.5.3.1.Market size and forecast, by Type; 7.4.5.3.2.Market size and forecast, by Form; 7.4.5.3.3.Market size and forecast, by Sales channel; 7.4.5.4.Australia; 7.4.5.4.1.Market size and forecast, by Type; 7.4.5.4.2.Market size and forecast, by Form; 7.4.5.4.3.Market size and forecast, by Sales channel; 7.4.5.5.South Korea; 7.4.5.5.1.Market size and forecast, by Type; 7.4.5.5.2.Market size and forecast, by Form; 7.4.5.5.3.Market size and forecast, by Sales channel; 7.4.5.6.Rest of Asia-Pacific; 7.4.5.6.1.Market size and forecast, by Type; 7.4.5.6.2.Market size and forecast, by Form; 7.4.5.6.3.Market size and forecast, by Sales channel; 7.5.LAMEA; 7.5.1.Key market trends, growth factors, and opportunities; 7.5.2.Market size and forecast, by Type; 7.5.3.Market size and forecast, by Form; 7.5.4.Market size and forecast, by Sales channel; 7.5.5.Market analysis, by country; 7.5.5.1.Brazil; 7.5.5.1.1.Market size and forecast, by Type; 7.5.5.1.2.Market size and forecast, by Form; 7.5.5.1.3.Market size and forecast, by Sales channel; 7.5.5.2.Argentina; 7.5.5.2.1.Market size and forecast, by Type; 7.5.5.2.2.Market size and forecast, by Form; 7.5.5.2.3.Market size and forecast, by Sales channel; 7.5.5.3.Saudi Arabia; 7.5.5.3.1.Market size and forecast, by Type; 7.5.5.3.2.Market size and forecast, by Form; 7.5.5.3.3.Market size and forecast, by Sales channel; 7.5.5.4.United Arab Emirates; 7.5.5.4.1.Market size and forecast, by Type; 7.5.5.4.2.Market size and forecast, by Form; 7.5.5.4.3.Market size and forecast, by Sales channel; 7.5.5.5.South Africa; 7.5.5.5.1.Market size and forecast, by Type; 7.5.5.5.2.Market size and forecast, by Form; 7.5.5.5.3.Market size and forecast, by Sales channel; 7.5.5.6.Rest of LAMEA; 7.5.5.6.1.Market size and forecast, by Type; 7.5.5.6.2.Market size and forecast, by Form; 7.5.5.6.3.Market size and forecast, by Sales channel
CHAPTER 8:COMPETITION LANDSCAPE: 8.1.Overview; 8.2.Competitive dashboard; 8.3.Competitive heat map; 8.4.Product mapping; 8.5.Top winning strategies; 8.6.Key developments; 8.6.1.Acquisition; 8.6.2.Business Expansion; 8.6.3.Joint Venture; 8.6.4.Partnership; 8.6.5.Product Launch; 8.7.Top Player Positioning
CHAPTER 9:COMPANY PROFILES: 9.1.ARCHER DANIELS MIDLAND COMPANY; 9.1.1.Company overview; 9.1.2.Key executive; 9.1.3.Company snapshot; 9.1.4.Operating business segments; 9.1.5.Product portfolio; 9.1.6.R&D expenditure; 9.1.7.Business performance; 9.1.8.Key strategic moves and developments; 9.2.BASF SE; 9.2.1.Company overview; 9.2.2.Key Executives; 9.2.3.Company snapshot; 9.2.4.Operating business segments; 9.2.5.Product portfolio; 9.2.6.Business performance; 9.2.7.Key strategic moves and developments; 9.3.CARGILL, INC.; 9.3.1.Company overview; 9.3.2.Key executives; 9.3.3.Company snapshot; 9.3.4.Operating business segments; 9.3.5.Product portfolio; 9.3.6.Business performance; 9.3.7.Key strategic moves and developments; 9.4.DANONE; 9.4.1.Company overview; 9.4.2.Key Executives; 9.4.3.Company snapshot; 9.4.4.Operating business segments; 9.4.5.Product portfolio; 9.4.6.Business performance; 9.4.7.Key strategic moves and developments; 9.5.DUPONT DE NEMOURS, INC.; 9.5.1.Company overview; 9.5.2.Key Executives; 9.5.3.Company snapshot; 9.5.4.Operating business segments; 9.5.5.Product portfolio; 9.5.6.R&D Expenditure; 9.5.7.Business performance; 9.6.GENERAL MILLS INC.; 9.6.1.Company overview; 9.6.2.Key executives; 9.6.3.Company snapshot; 9.6.4.Operating business segments; 9.6.5.Product portfolio; 9.6.6.R&D expenditure; 9.6.7.Business performance; 9.6.8.Key strategic moves and developments; 9.7.KONINKLIJKE DSM N.V.; 9.7.1.Company overview; 9.7.2.Key executive; 9.7.3.Company snapshot; 9.7.4.Operating business segments; 9.7.5.Product portfolio; 9.7.6.R&D expenditure (Continued and discontinued operations); 9.7.7.Business performance (Continued and discontinued operations); 9.8.NESTLE S.A.; 9.8.1.Company overview; 9.8.2.Key Executives; 9.8.3.Company snapshot; 9.8.4.Operating business segments; 9.8.5.Product portfolio; 9.8.6.R&D Expenditure; 9.8.7.Business performance; 9.8.8.Key strategic moves and developments; 9.9.PEPSICO, INC.; 9.9.1.Company overview; 9.9.2.Key Executives; 9.9.3.Company snapshot; 9.9.4.Operating business segments; 9.9.5.Product portfolio; 9.9.6.R&D Expenditure; 9.9.7.Business performance; 9.9.8.Key strategic moves and developments; 9.10.YAKULT HONSHA CO., LTD.; 9.10.1.Company overview; 9.10.2.Key Executives; 9.10.3.Company snapshot; 9.10.4.Operating business segments; 9.10.5.Product portfolio; 9.10.6.R&D Expenditure; 9.10.7.Business performance; 9.10.8.Key strategic moves and developments
LIST OF TABLES: TABLE 01.NUTRACEUTICALS MARKET, BY TYPE, 2020–2030 ($ MILLION); TABLE 02.FUNCTIONAL BEVERAGES NUTRACEUTICALS MARKET, BY REGION, 2020–2030 ($ MILLION); TABLE 03.FUNCTIONAL FOOD NUTRACEUTICALS MARKET, BY REGION, 2020–2030 ($ MILLION); TABLE 04.DIETARY SUPPLEMENTS NUTRACEUTICALS MARKET, BY REGION, 2020–2030 ($ MILLION); TABLE 05.NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION); TABLE 06.CAPSULE AND TABLETS NUTRACEUTICALS MARKET, BY REGION, 2020–2030 ($ MILLION); TABLE 07.LIQUID NUTRACEUTICALS MARKET, BY REGION, 2020–2030 ($ MILLION); TABLE 08.POWDER NUTRACEUTICALS MARKET, BY REGION, 2020–2030 ($ MILLION); TABLE 09.OTHERS NUTRACEUTICALS MARKET, BY REGION, 2020–2030 ($ MILLION); TABLE 10.NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 11.NUTRACEUTICALS MARKET SALES VIA HYPERMARKET/SUPERMARKET, BY REGION, 2020–2030 ($ MILLION); TABLE 12.NUTRACEUTICALS MARKET SALES VIA SPECIALTY STORES, BY REGION, 2020–2030 ($ MILLION); TABLE 13.NUTRACEUTICALS MARKET SALES VIA PHARMACY, BY REGION, 2020–2030 ($ MILLION); TABLE 14.NUTRACEUTICALS MARKET SALES VIA ONLINE CHANNELS, BY REGION, 2020–2030 ($ MILLION); TABLE 15.NUTRACEUTICALS MARKET, BY REGION, 2020–2030 ($ MILLION); TABLE 16.NORTH AMERICA NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 17.NORTH AMERICA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 18.NORTH AMERICA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 19.NORTH AMERICA NUTRACEUTICALS MARKET VALUE, BY COUNTRY, 2020–2030 ($ MILLION); TABLE 20.U.S. NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 21.U.S. NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION); TABLE 22.U.S. NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 23.CANADA NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 24.CANADA NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION); TABLE 25.CANADA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 26.MEXICO NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 27.MEXICO NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION); TABLE 28.MEXICO NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 29.EUROPE NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 30.EUROPE NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 31.EUROPE NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 32.EUROPE NUTRACEUTICALS MARKET VALUE, BY COUNTRY, 2020–2030 ($ MILLION); TABLE 33.UK NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 34.UK NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION); TABLE 35.UK NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 36.GERMANY NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 37.GERMANY NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION); TABLE 38.GERMANY NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 39.ITALY NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 40.ITALY NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION); TABLE 41.ITALY NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 42.FRANCE NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 43.FRANCE NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION); TABLE 44.FRANCE NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 45.SPAIN NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 46.SPAIN NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION); TABLE 47.SPAIN NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 48.REST OF EUROPE NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 49.REST OF EUROPE NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION); TABLE 50.REST OF EUROPE NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 51.ASIA-PACIFIC NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 52.ASIA-PACIFIC NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 53.ASIA-PACIFIC NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 54.ASIA-PACIFIC NUTRACEUTICALS MARKET VALUE, BY COUNTRY, 2020–2030 ($ MILLION); TABLE 55.CHINA NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 56.CHINA NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION); TABLE 57.CHINA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 58.JAPAN NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 59.JAPAN NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION); TABLE 60.JAPAN NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 61.INDIA NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 62.INDIA NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION); TABLE 63.INDIA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 64.AUSTRALIA NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 65.AUSTRALIA NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION); TABLE 66.AUSTRALIA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 67.SOUTH KOREA NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 68.SOUTH KOREA NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION); TABLE 69.SOUTH KOREA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 70.REST OF ASIA-PACIFIC NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 71.REST OF ASIA-PACIFIC NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION); TABLE 72.REST OF ASIA-PACIFIC NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 73.LAMEA NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 74.LAMEA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 75.LAMEA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 76.LAMEA NUTRACEUTICALS MARKET VALUE, BY COUNTRY, 2020–2030 ($ MILLION); TABLE 77.BRAZIL NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 78.BRAZIL NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION); TABLE 79.BRAZIL NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 80.ARGENTINA NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 81.ARGENTINA NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION); TABLE 82.ARGENTINA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 83.SAUDI ARABIA NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 84.SAUDI ARABIA NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION); TABLE 85.SAUDI ARABIA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 86.UNITED ARAB EMIRATES NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 87.UNITED ARAB EMIRATES NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION); TABLE 88.UNITED ARAB EMIRATES NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 89.SOUTH AFRICA NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 90.SOUTH AFRICA NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION); TABLE 91.SOUTH AFRICA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 92.REST OF LAMEA NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION); TABLE 93.REST OF LAMEA NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION); TABLE 94.REST OF LAMEA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION); TABLE 95.ARCHER DANIELS MIDLAND COMPANY: KEY EXECUTIVE; TABLE 96.ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT; TABLE 97.ARCHER DANIELS MIDLAND COMPANY: OPERATING SEGMENTS; TABLE 98.ARCHER DANIELS MIDLAND COMPANY: PRODUCT PORTFOLIO; TABLE 99.ARCHER DANIELS MIDLAND COMPANY: R&D EXPENDITURE, 2018-2020 ($MILLION); TABLE 100.ARCHER DANIELS MIDLAND COMPANY: NET SALES, 2018-2020 ($MILLION); TABLE 101.BASF SE: KEY EXECUTIVES; TABLE 102.BASF SE: COMPANY SNAPSHOT; TABLE 103.BASF SE: OPERATING SEGMENTS; TABLE 104.BASF SE: PRODUCT PORTFOLIO; TABLE 105.BASF SE: NET SALES, 2018-2020 ($MILLION); TABLE 106.CARGILL, INC.: KEY EXECUTIVES; TABLE 107.CARGILL, INC.: COMPANY SNAPSHOT; TABLE 108.CARGILL, INC.: OPERATING SEGMENTS; TABLE 109.CARGILL, INC..: PRODUCT PORTFOLIO; TABLE 110.CARGILL, INC.: NET SALES, 2020-2021 ($MILLION); TABLE 111.DANONE: KEY EXECUTIVES; TABLE 112.DANONE: COMPANY SNAPSHOT; TABLE 113.DANONE: OPERATING SEGMENTS; TABLE 114.DANONE: PRODUCT PORTFOLIO; TABLE 115.DANONE: NET SALES, 2018–2020 ($MILLION); TABLE 116.DUPONT DE NEMOURS, INC.: KEY EXECUTIVES; TABLE 117.DUPONT DE NEMOURS, INC.: COMPANY SNAPSHOT; TABLE 118.DUPONT DE NEMOURS, INC.: OPERATING SEGMENTS; TABLE 119.DUPONT DE NEMOURS, INC.: PRODUCT PORTFOLIO; TABLE 120.DUPONT DE NEMOURS, INC.: R&D EXPENDITURE, 2018–2020 ($MILLION); TABLE 121.DUPONT DE NEMOURS, INC.: NET SALES, 2018–2020 ($MILLION); TABLE 122.GENERAL MILLS INC.: KEY EXECUTIVES; TABLE 123.GENERAL MILLS INC.: COMPANY SNAPSHOT; TABLE 124.GENERAL MILLS INC.: OPERATING SEGMENTS; TABLE 125.GENERAL MILLS INC.: PRODUCT PORTFOLIO; TABLE 126.GENERAL MILLS INC.: R&D EXPENDITURE, 2018–2020 ($MILLION); TABLE 127.GENERAL MILLS INC.: NET SALES, 2018–2020 ($MILLION); TABLE 128.KONINKLIJKE DSM N.V.: KEY EXECUTIVE; TABLE 129.KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT; TABLE 130.KONINKLIJKE DSM N.V.: OPERATING SEGMENTS; TABLE 131.KONINKLIJKE DSM N.V.: PRODUCT PORTFOLIO; TABLE 132.KONINKLIJKE DSM N.V.: R&D EXPENDITURE, 2018-2020 ($MILLION); TABLE 133.KONINKLIJKE DSM N.V.: NET SALES, 2018-2020 ($MILLION); TABLE 134.NESTLE S.A.: KEY EXECUTIVES; TABLE 135.NESTLE S.A.: COMPANY SNAPSHOT; TABLE 136.NESTLE S.A.: OPERATING SEGMENTS; TABLE 137.NESTLE S.A.: PRODUCT PORTFOLIO; TABLE 138.NESTLE S.A.: R&D EXPENDITURE, 2018–2020 ($MILLION); TABLE 139.NESTLE S.A.: NET SALES, 2018–2020 ($MILLION); TABLE 140.PEPSICO, INC.: KEY EXECUTIVES; TABLE 141.PEPSICO, INC.: COMPANY SNAPSHOT; TABLE 142.PEPSICO, INC.: OPERATING SEGMENTS; TABLE 143.PEPSICO, INC.: PRODUCT PORTFOLIO; TABLE 144.PEPSICO, INC.: R&D EXPENDITURE, 2018–2020 ($MILLION); TABLE 145.PEPSICO, INC.: NET SALES, 2018–2020 ($MILLION); TABLE 146.YAKULT HONSHA CO., LTD.: KEY EXECUTIVES; TABLE 147.YAKULT HONSHA CO., LTD.: COMPANY SNAPSHOT; TABLE 148.YAKULT HONSHA CO., LTD.: OPERATING SEGMENTS; TABLE 149.YAKULT HONSHA CO., LTD.: PRODUCT PORTFOLIO; TABLE 150.YAKULT HONSHA CO., LTD.: R&D EXPENDITURE, 2018–2020 ($MILLION); TABLE 151.YAKULT HONSHA CO., LTD.: NET SALES, 2018–2020 ($MILLION)
LIST OF FIGURES: FIGURE 01.KEY MARKET SEGMENTS; FIGURE 02.EXECUTIVE SUMMARY; FIGURE 03.TOP IMPACTING FACTORS; FIGURE 04.TOP INVESTMENT POCKETS; FIGURE 05.MODERATE BARGAINING POWER OF SUPPLIERS; FIGURE 06.HIGH BARGAINING POWER OF BUYERS; FIGURE 07.LOW THREAT OF SUBSTITUTION; FIGURE 08.MODERATE THREAT OF NEW ENTRANTS; FIGURE 09.HIGH INTENSITY OF COMPETITIVE RIVALRY; FIGURE 10.NUTRACEUTICALS MARKET, BY TYPE, 2020 (%); FIGURE 11.COMPARATIVE VALUE SHARE ANALYSIS OF FUNCTIONAL BEVERAGES NUTRACEUTICALS MARKET, BY COUNTRY, 2020 & 2030 (%); FIGURE 12.COMPARATIVE VALUE SHARE ANALYSIS OF FUNCTIONAL FOOD NUTRACEUTICALS MARKET, BY COUNTRY, 2020 & 2030 (%); FIGURE 13.COMPARATIVE VALUE SHARE ANALYSIS OF DIETARY SUPPLEMENTS NUTRACEUTICALS MARKET, BY COUNTRY, 2020 & 2030 (%); FIGURE 14.NUTRACEUTICALS MARKET, BY FORM, 2020 (%); FIGURE 15.COMPARATIVE VALUE SHARE ANALYSIS OF CAPSULE AND TABLETS NUTRACEUTICALS MARKET, BY COUNTRY, 2020 & 2030 (%); FIGURE 16.COMPARATIVE VALUE SHARE ANALYSIS OF LIQUID NUTRACEUTICALS MARKET, BY COUNTRY, 2020 & 2030 (%); FIGURE 17.COMPARATIVE VALUE SHARE ANALYSIS OF POWDER NUTRACEUTICALS MARKET, BY COUNTRY, 2020 & 2030 (%); FIGURE 18.COMPARATIVE VALUE SHARE ANALYSIS OF OTHERS NUTRACEUTICALS MARKET, BY COUNTRY, 2020 & 2030 (%); FIGURE 19.NUTRACEUTICALS MARKET, BY SALES CHANNEL, 2020 (%); FIGURE 20.COMPARATIVE VALUE SHARE ANALYSIS OF NUTRACEUTICALS SALES VIA HYPERMARKET/SUPERMARKET, BY COUNTRY, 2020 & 2030 (%); FIGURE 21.COMPARATIVE VALUE SHARE ANALYSIS OF NUTRACEUTICALS SALES VIA SPECIALTY STORES, BY COUNTRY, 2020 & 2030 (%); FIGURE 22.COMPARATIVE VALUE SHARE ANALYSIS OF NUTRACEUTICALS SALES VIA PHARMACY, BY COUNTRY, 2020 & 2030 (%); FIGURE 23.COMPARATIVE VALUE SHARE ANALYSIS OF NUTRACEUTICALS SALES VIA ONLINE CHANNELS, BY COUNTRY, 2020 & 2030 (%); FIGURE 24.NUTRACEUTICALS MARKET, BY REGION 2020 (%); FIGURE 25.U.S. NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION); FIGURE 26.CANADA NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION); FIGURE 27.MEXICO NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION); FIGURE 28.UK NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION); FIGURE 29.GERMANY NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION); FIGURE 30.ITALY NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION); FIGURE 31.FRANCE NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION); FIGURE 32.SPAIN NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION); FIGURE 33.REST OF EUROPE NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION); FIGURE 34.CHINA NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION); FIGURE 35.JAPAN NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION); FIGURE 36.INDIA NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION); FIGURE 37.AUSTRALIA NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION); FIGURE 38.SOUTH KOREA NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION); FIGURE 39.REST OF ASIA-PACIFIC NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION); FIGURE 40.BRAZIL NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION); FIGURE 41.ARGENTINA NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION); FIGURE 42.SAUDI ARABIA NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION); FIGURE 43.UNITED ARAB EMIRATES NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION); FIGURE 44.SOUTH AFRICA NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION); FIGURE 45.REST OF LAMEA NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION); FIGURE 46.COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS; FIGURE 47.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS; FIGURE 48.PRODUCT MAPPING OF TOP 10 KEY PLAYERS; FIGURE 49.TOP WINNING STRATEGIES, BY YEAR, 2018–2021*; FIGURE 50.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021* (%); FIGURE 51.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021*; FIGURE 52.PLAYER POSITIONING OF TOP 10 KEY PLAYERS; FIGURE 53.ARCHER DANIELS MIDLAND COMPANY: R&D EXPENDITURE, 2018-2020 ($MILLION); FIGURE 54.ARCHER DANIELS MIDLAND COMPANY: NET SALES, 2018-2020 ($MILLION); FIGURE 55.ARCHER DANIELS MIDLAND COMPANY: REVENUE SHARE BY SEGMENT, 2020 (%); FIGURE 56.ARCHER DANIELS MIDLAND COMPANY: REVENUE SHARE BY REGION, 2020 (%); FIGURE 57.BASF SE: NET SALES, 2018-2020 ($MILLION); FIGURE 58.BASF SE: REVENUE SHARE BY SEGMENT, 2020 (%); FIGURE 59.BASF SE: REVENUE SHARE BY REGION, 2020 (%); FIGURE 60.CARGILL, INC..: NET SALES, 2020-2021 ($MILLION); FIGURE 61.DANONE: NET SALES, 2018–2020 ($MILLION); FIGURE 62.DANONE: REVENUE SHARE BY SEGMENT, 2020 (%); FIGURE 63.DUPONT DE NEMOURS, INC.: R&D EXPENDITURE, 2018–2020 ($MILLION); FIGURE 64.DUPONT DE NEMOURS, INC.: NET SALES, 2018–2020 ($MILLION); FIGURE 65.DUPONT DE NEMOURS, INC.: REVENUE SHARE BY SEGMENT, 2020 (%); FIGURE 66.DUPONT DE NEMOURS, INC.: REVENUE SHARE BY REGION, 2020 (%); FIGURE 67.GENERAL MILLS INC.: R&D EXPENDITURE, 2018–2020 ($MILLION); FIGURE 68.GENERAL MILLS INC.: NET SALES, 2018–2020 ($MILLION); FIGURE 69.GENERAL MILLS INC.: REVENUE SHARE BY SEGMENT, 2020 (%); FIGURE 70.GENERAL MILLS INC.: REVENUE SHARE BY REGION, 2020 (%); FIGURE 71.KONINKLIJKE DSM N.V.: R&D EXPENDITURE, 2018-2020 ($MILLION); FIGURE 72.KONINKLIJKE DSM N.V.: NET SALES, 2018-2020 ($MILLION); FIGURE 73.KONINKLIJKE DSM N.V.: REVENUE SHARE BY SEGMENT, 2020 (%); FIGURE 74.KONINKLIJKE DSM N.V.: REVENUE SHARE BY REGION, 2020 (%); FIGURE 75.NESTLE S.A.: R&D EXPENDITURE, 2018–2020 ($MILLION); FIGURE 76.NESTLE S.A.: NET SALES, 2018–2020 ($MILLION); FIGURE 77.NESTLE S.A.: REVENUE SHARE BY SEGMENT, 2020 (%); FIGURE 78.NESTLE S.A.: REVENUE SHARE BY REGION, 2020 (%); FIGURE 79.PEPSICO, INC.: R&D EXPENDITURE, 2018–2020 ($MILLION); FIGURE 80.PEPSICO, INC.: NET SALES, 2018–2020 ($MILLION); FIGURE 81.PEPSICO, INC.: REVENUE SHARE BY SEGMENT, 2020 (%); FIGURE 82.YAKULT HONSHA CO., LTD.: R&D EXPENDITURE, 2018–2020 ($MILLION); FIGURE 83.YAKULT HONSHA CO., LTD.: NET SALES, 2018–2020 ($MILLION); FIGURE 84.YAKULT HONSHA CO., LTD.: REVENUE SHARE BY SEGMENT, 2020 (%); FIGURE 85.YAKULT HONSHA CO., LTD.: REVENUE SHARE BY REGION, 2020 (%)